Pharmacological profile of ρ-Da1a binding to various human AR subtypes expressed in eukaryotic cells.

Binding inhibition curves for 3H-prazosin (2 nM), 3H-rauwolscine (2 nM) and 3H-CGP-12177 (6 nM) on hα1A- (1 µg, ○), hα1B- (3 µg, •), hα1D- (29 µg, □), hα2A- (140 µg, ◊), hα2B- (100 µg, Δ), hα2C- (3 µg, x), β1- (3 µg,▾) and β2-AR (1.5 µg, ▪) with recombinant ρ-Da1a. n = 4.